Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pragmatic randomized multicenter comparison of fingolimod versus dimethyl fumarate in relapsing-remitting multiple sclerosis
MOH_2018-08-14_002522Phase 4Completed
- Sponsor
- פרופ' אריאל מילר
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in multiple sclerosis (MS) comparing Fingolimod with Dimethyl fumarate (2 arms). Started Aug 2018; status: completed.
02
Drugs
fingolimoddimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on MOH_2018-08-14_002522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-08-14_002522.